Ongoing Fertility Trials: Can You Really Reverse Menopause?

By: Fertility CARE
Spread the Word
Listed Under

* Fertility
* Menopause

* Health

* Winter Park - Florida - US

* Reports

WINTER PARK, Fla. - Feb. 20, 2018 - PRLog -- A breakthrough treatment in reversing menopause and restoring female fertility is showing novel impacts on mitigating the effects of the aging process. In its latest study, of which Fertility CARE: The IVF Center is the only partner research facility on the east coast, Inovium Ovarian Rejuvenation ( released preliminary data from ongoing clinical trials.

Preliminary results indicate improved follicle response, live births, pregnancy, positive IVF, increased egg quality and quantity, and substantial increases in overall physical health.

"We are honored to have been the only research center on the east coast chosen to participate in this groundbreaking study," says Mark P. Trolice, M.D. , director of Fertility CARE: The IVF Center. "The results show this treatment could be a significant breakthrough for women who are having difficulty responding to (fertility) medication and even ovarian failure."

"The results show this treatment could be a significant breakthrough for women who are having difficulty responding to (fertility) medication and even ovarian failure."

Preliminary results from the world's first clinical trials to reverse menopause and its associated negative health effects in women has shown reversal of menopausal symptoms and hormone restoration to fertile levels. Since July 2017, the California-based Inovium trials have been evaluating the link between a new treatment to restore ovarian function discovered in 2015 by partner clinicians in Athens, Greece.

New clinical locations have recently launched in collaboration with Dr. Trolice's Winter Park-area fertility clinic. Approximately 10 women and their partners so far have been selected to move forward in the trial, which will further examine their progress as they begin In Vitro Fertilization (IVF) and other strategies for late-life pregnancy. Over 100 additional women have received the treatment in 2017, with 60 – 75 percent of all women proceeding forward positively towards pregnancy.

The patient's own blood platelet-derived growth factors are infused into her ovaries to potentially avoid the need for an egg donor. The basic process involves processing the patient's own blood plasma, enrichment via centrifuge, and reinjection her platelet-rich plasma with the hope of restoring ovarian function and/or fertility. Enrollment is now open for the trials, which are conducted in Winter Park, FL, Carlsbad, CA, and Encino, CA, Los Angeles, CA and Las Vegas, NV.

Women who have severe ovarian aging and/or have entered menopause and would like to potentially regain fertility and healthy hormone and energy levels are encouraged to sign up at for more information.

Anonymized clinical data is available for release upon request, as well as interviews with patients currently proceeding forward with successful pregnancies as a result of the treatment.

Mark Trolice
Email:*** Email Verified
Tags:Fertility, Menopause
Location:Winter Park - Florida - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Insight Marketing Group News
Most Viewed
Daily News

Like PRLog?
Click to Share